Factors associated with testing for HIV in people aged ≥50 years

BMC Public Health 2018 18:1204

https://doi.org/10.1186/s12889-018-6118-x

Published: 26 October 2018

Factors associated with testing for HIV in people aged ≥50 years: a qualitative study

Abstract

Background

Despite a decline in the number of new HIV infections in the UK overall, the number and proportion of new HIV diagnoses in people aged ≥50 years continues to increase. People aged ≥50 years are disproportionately affected by late diagnosis, which is associated with poorer health outcomes, increased treatment complexity and increased healthcare costs. Late HIV diagnosis also has significant public health implications in terms of onward HIV transmission. It is not fully understood what factors affect the decision of an older person to test for HIV. The aim of this study was to identify factors associated with testing for HIV in people aged ≥50 years who tested late for HIV.

Methods

We interviewed 20 people aged ≥50 years diagnosed late with HIV to identify factors associated with HIV testing. Interviews were audio recorded, transcribed verbatim and thematically analysed.

Results

Seven themes associated with HIV testing in people aged ≥50 years were identified: experience of early HIV/AIDS campaigns, HIV knowledge, presence of symptoms and symptom attribution, risk and risk perception, generational approaches to health and sexual health, stigma, and type of testing and testing venue.

Conclusion

Some factors associated with testing identified in this study were unique to older individuals. People aged ≥50 years often do not perceive themselves to be at risk of HIV. Further, stigma and a lack of knowledge of how to access HIV testing suggest a need for health promotion and suggest current sexual health services may need to adapt to better meet their needs.

Hepatitis C Virus – for GPs, Nurses and Allied Health Professionals

Sonder, October 2018

In this education session, presenters Dr Dep Huynh, Ms Margery Milner and Mr Jeff Stewart will provide attendees with an update on the risk factors associated with Hepatitis C Virus (HCV) and the management options available.

The presenters will also provide information on liver cirrhosis tests and how to choose and initiate the most appropriate HCV treatment for patients.

Learning objectives

  • Identify and understand the risk factors for HCV screening;
  • Perform correct diagnosis of chronic HCV using reflexive testing;
  • Assess and manage patients for liver cirrhosis using non-invasive tests;
  • Improve patient safety by choosing the most appropriate HCV treatment according to the patient’s characteristics and co-medications;
  • Discuss and improve your understanding on how to initiate HCV treatment.

Presented by

Dr Dep Huynh, Gastroentrologist & Staff Specialist at Queen Elizabeth Hospital,
Clinical Lecturer, University of South Australia

Margery Milner & Jeff Stewart, Nurses at Queen Elizabeth Hospital

Agenda

6.30pm – 7.00pm Registration and dinner
7.00pm – 8.00pm Presentation by Dr Dep Huynh, Gastroentrologist & Staff Specialist at Queen Elizabeth Hospital, Clinical Lecturer, University of South Australia8.00pm – 8.10pm Tea/coffee break
8.10pm – 9.10pm Presentation by Margery Milner & Jeff Stewart, Nurses at Queen Elizabeth Hospital
9.10pm – 9.30pm Questions, evaluation & close

RACGP QI & CPD Category 2, 4 Points

DATE AND TIME

Mon. 5 November 2018

6:15 pm – 9:30 pm ACDT

LOCATION

Arya Restaurant

30/81 O’Connell Street

North Adelaide, SA 5006

This program is funded by the Adelaide Primary Health Network - an Australian Government initiative

 

Translation and implementation of the Australian-led PCOS guideline

Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Med J Aust 2018; 209 (7 Suppl): S3-S8. || doi: 10.5694/mja18.00656
Published online: 2018-10-01

Abstract

Introduction: We have developed the first international evidence-based guideline for the diagnosis and management of polycystic ovary syndrome (PCOS), with an integrated translation program incorporating resources for health professionals and consumers. The development process involved an extensive Australian-led international and multidisciplinary collaboration of health professionals and consumers over 2 years. The guideline is approved by the National Health and Medical Research Council and aims to support both health professionals and women with PCOS in improving care, health outcomes and quality of life. A robust evaluation process will diagnoenable practice benchmarking and feedback to further inform evidence-based practice. We propose that this methodology could be used in developing and implementing guidelines for other women’s health conditions and beyond.

Main recommendations: The recommendations cover the following broad areas: diagnosis, screening and risk assessment depending on life stage; emotional wellbeing; healthy lifestyle; pharmacological treatment for non-fertility indications; and assessment and treatment of infertility.

Changes in management as a result of this guideline: •Diagnosis:▪when the combination of hyperandrogenism and ovulatory dysfunction is present, ultrasound examination of the ovaries is not necessary for diagnosis of PCOS in adult women;▪requires the combination of hyperandrogenism and ovulatory dysfunction in young women within 8 years of menarche, with ultrasound examination of the ovaries not recommended, owing to the overlap with normal ovarian physiology; and▪adolescents with some clinical features of PCOS, but without a clear diagnosis, should be regarded as “at risk” and receive follow-up assessment.•Screening for metabolic complications has been refined and incorporates both PCOS status and additional metabolic risk factors.•Treatment of infertility: letrozole is now first line treatment for infertility as it improves live birth rates while reducing multiple metapregnancies compared with clomiphene citrate.

New clinic posters for download from Young Deadly Free

Young Deadly Free, October 2018

The team at Young Deadly Free have been busy creating new posters with Aboriginal communities across Australia. The posters aim to get their key messages out to young people and others in a fresh, engaging way.

All of our posters highlight positive messages from people living and working in Aboriginal and Torres Strait Islander communities about the importance of STI and BBV testing.

  • View and download their 36 new posters here

Indigenous Risk Impact Screen Training – Upcoming Dates

Drug and Alcohol Services South Australia (DASSA), August 2018

DASSA’s Aboriginal Workforce Development team would like to invite you to attend the 2-day Indigenous Risk Impact Screen training workshop.

The Indigenous Risk Impact Screen is a validated culturally appropriate and widely used tool for screening substance use and mental disorders in Aboriginal clients. It has been developed in partnership with Aboriginal communities and is used throughout Australia. The purpose of the training is to provide participants with the skills to screen, assess and deliver these clients, a brief intervention that is culturally secure. The workshop includes training in the use of the IRIS screening instrument, a two factor screen that assesses alcohol and other drugs and associated mental health issues.

The target audience is people working in the health and community sector who have contact with Aboriginal and Torres Strait Islander clients who may have emotional health and/or alcohol and other drug issues.

The training is free to attend. Sessions will be held in Adelaide (booked out), Ceduna, Coober Pedy & Mount Gambier. Please see attached promotional document for details with date and venue.

Cervical Screening Update recording now available!

Quote

SHINE SA, August 2018

SHINE SA is proud to present our pilot Clinical Education Forum recording. This recording is available free of charge,  and access is limited to three months only.

Topic: Cervical Screening Update

Presenters: Megan van Zanten & Dr Amy Moten

The forum ensures your knowledge of the National Cervical Screening Renewed Guidelines is accurate and in line with best practice principles.

  • To watch the recording click the link here and set up a free account/sign in. Under Course Categories click Clinical Education to find the course, and then click Enrol Me. You can now watch the recording.